Finnrick - Ensuring Safe and Transparent Supply Chain
NextechLabs

NextechLabs
Tirzepatide

Finnrick tested 6 samples of Tirzepatide (GLP-1 and GIP antagonist) from NextechLabs between 14 Jan 2025 and 20 Mar 2025. Tests score average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).

Finnrick Rating™
C
OKAY
NextechLabs
Tirzepatide
Tested 6 Samples
Last test 20 Mar 2025

Take Action

Mail in a Sample

We test your peptides for free: mail in a sample you have (US only), or request us to test a vendor.

Tirzepatide is also available from top-rated vendors:

All Tirzepatide tests from NextechLabs

Samples are tested in commercial labs

Tests Count

6

Scores

AVG6.2MIN5.0MAX7.3

Last

20 Mar 2025

First

14 Jan 2025
Quantity
Test Date
Test Score
Label
Batch
TestedDifferencePurityBatch IDContainerTested AtSent By
20 Mar 20257.130mg(no batch claim)35.420mg+18.1%99.84%2024-09-23Blue Label / Red CapLab BFinnrick
28 Feb 20255.730mg(no batch claim)36.597mg+22.0%99.36%2024-09-23Blue Label / Red CapLab CFinnrick
28 Feb 20257.330mg(no batch claim)35.112mg+17.0%99.89%2024-09-23Blue Label / Red CapLab CFinnrick
27 Feb 20256.230mg(no batch claim)37.540mg+25.1%99.62%2024-09-23Blue Label / Red CapLab AFinnrick
23 Jan 20255.710mg
9.4mg
12.330mg+30.8%99.83%2024-09-23(no data)Lab BFinnrick
14 Jan 20255.010mg
9.4mg
13.690mg+45.2%99.61%2024-09-23(no data)Lab AFinnrick

Corrections

17 Apr 2025
Lab A test 27 Feb 2025, lab C test 28 Feb 2025, lab B test 30 Mar 2025: updated batch claim quantity, label claim was clear, erroneously listed 10mg.